• Friday, Feb 03, 2023
  • Last Update : 10:24 am

India's Bharat Biotech seeks Bangladesh trial for Covid-19 vaccine approved at home

  • Published at 09:21 am January 21st, 2021
Indian Health Minister Harsh Vardhan
File Photo: Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called COVAXIN, during a vaccination in New Delhi, India on January 16, 2021 Reuters

Bangladesh started receiving millions of India-made doses of another vaccine licensed from Oxford University and AstraZeneca

India’s Bharat Biotech has applied to conduct trials in Bangladesh for its coronavirus vaccine recently approved for emergency use at home, a senior official at Bangladesh’s main medical research body told Reuters.

If allowed to go ahead, this would be the first trial of any coronavirus vaccine in Bangladesh and could give the densely-populated country of more than 160 million faster access to the shot for mass use.

The vaccine, developed with the Indian Council of Medical Research, was given the green light for restricted use in India this month without any efficacy data from a late-stage trial. Early tests, however, found it to be safe and generating an immune response in humans.

“We have received their proposal,” said Mahmood-uz-Jahan, a director at the state-run Bangladesh Medical Research Council, adding that its ethics committee would review the application.

He declined to give details.

The Dhaka-based International Centre for Diarrhoea Disease Research, Bangladesh (ICDDR,B), has applied to run the trial on behalf of Bharat Biotech, said a source with direct knowledge of the matter who declined to be named citing internal rules.

ICDDR,B declined to comment. Spokespeople for Bharat Biotech had no immediate comment.

Sinovac Biotech’s late-stage trial of a potential vaccine in Bangladesh has become uncertain after Dhaka refused to meet the Chinese company’s demand for co-funding.

Bharat Biotech started a late-stage trial for COVAXIN at home in November and a top Indian government vaccine official, Vinod Kumar Paul, has told Reuters that a smaller study involving 1,000-2,000 people could also be done in Bangladesh.

Bangladesh started receiving millions of India-made doses of another vaccine licensed from Oxford University and AstraZeneca on Thursday. It is being mass produced by the Serum Institute of India, the world’s largest vaccine maker.

Bangladesh, however, has no immediate plans to buy COVAXIN whose efficacy data from the late India trial are expected by March.

“Our vaccine procurement is in good shape. We are going to start the vaccination in the first week of February,” Bangladesh Health Secretary Abdul Mannan told Reuters.

“No plan to buy from Bharat Biotech at present.”

Brazil is the only country that has publicly announced plans to buy COVAXIN doses from India.

The company on Thursday submitted an application for the emergency use of the vaccine in the Philippines.

Facebook 50
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail